Near-infrared spectroscopy (NIRS) is a noninvasive optical technique to monitor cerebral oxygen saturation at the bedside. Despite its applicability, NIRS has had limited clinical use because of concerns about accuracy, noted by intersubject variability in slope and intercept of the line between NIRS-and weighted-average arterial-cerebrovenous saturation (SMOG). This study evaluated transcranial optical pathlength and cerebral hemoglobin concentration as sources for this intersubject variability.
Experiments were performed in an in vitro brain model and in piglets. Optical pathlength and cerebral hemoglobin concentration were measured by time-resolved spectroscopy (TRS). NIRS and TRS were recorded in the model, as perfusate blood saturation was varied (0%-100%) at several hemoglobin concentrations, and in piglets, as SMO, was varied (15%-90%) before and after hemodilution.
In the model, hemoglobin concentration significantly altered the NIRS versus blood saturation line slope and intercept, as well as optical pathlength. In piglets (before hemodilution), there was significant intersubject variability in NIRS versus SMO, line slope (0.73-1.4) and intercept (-24 to 36) and in transcranial optical pathlength (13.4-16 cm) and cerebral hemoglobin concentration (0.58-1.1 g/dL). By adjusting the NIRS algorithm with optical pathlength or cerebral hemoglobin measurements, intersubject variability in slope (0.9-1.2) and intercept (-9 to 18) decreased significantly. Hemodilution significantly changed NIRS versus SMO, line slope and intercept, as well as transcranial optical pathlength and cerebral hemoglobin concentration (before versus after hemodilution: slope 0.9 vs 0.78, intercept 13 vs 19, pathlength 13.9 vs 15.6 cm, cerebral hemoglobin 0.98 vs 0.73 g/ dL). By adjusting the NIRS algorithm with the cerebral hemoglobin measurements, slope and intercept remained unchanged by hemodilution.
These data indicate that intersubject variability in NIRS originates, in part, from biologic variations in transcranial optical pathlength and cerebral hemoglobin concentration.
Instruments to account for these factors may improve NIRS cerebral oxygen saturation measurements. (Anesth Analg 1997; 84:1297- 1997;84:1297-305 saturation to validate NIRS oxygen saturation. Because NIRS oxygen saturation originates from within a field containing capillaries, arteries, and veins, it can be estimated from the combined saturation of arterial and venous blood calculated in proportion to their contribution to cerebral blood volume (approximately 25% arterial, 75% venous) (12). During graded hypoxia in human volunteers, they observed good correlations between NIRS and weighted-average saturation, although slopes and intercepts were not homogenous among the volunteers and agreement between the measures was often imprecise (10,ll). Wide intersubject variability in slope and intercept has also been observed by other investigators in humans (13) and in animals (7). The source of intersubject variability and apparent inaccuracy in NIRS oxygen saturation measurements has not been examined. However, in the derivation of oxygen saturation, NIRS makes several assumptions involving optical pathlength and hemoglobin concentration in the tissue field, which suggests that these factors might be a source of intersubject variability. In this study, the mathematical relationship among NIRS oxygen saturation, optical pathlength, and hemoglobin concentration is described, and the effect of optical pathlength and hemoglobin concentration on NIRS oxygen saturation measurements are examined experimentally in an in vitro model of the brain and in viva in piglets.
Methods
Theory NIRS relies on a modification of the Beer-Lambert law to derive cerebral oxygen saturation from light absorption differences between wavelengths to yield an expression
where G is measured light attenuation difference between wavelengths, H is brain tissue hemoglobin concentration, Sco, is cerebral oxygen saturation, and k and k' are lump constants (see Appendix A time-resolved spectrophotometer (TRS; Hamamatsu Photonics, Hamamatsu, Japan) was used to determine optical pathlength and cerebral hemoglobin concentration (14-16). The instrument consists of two fiberoptic bundles connected to a main unit housing picosecond-pulsed lasers emitting at 780 and 830 nm, a time-gated multichannel photon detector, and a computer. One fiberoptic bundle conveys the laser light pulses from the main unit to the head, and the other fiberoptic bundle receives the light emerging from the head and conveys it to the time-gated detector. The computer calculates transcranial optical pathlength from the "time-of-flight" (t) of photons from emitter to detector by the relationship
where c is the speed of light (30 cm/ns) and n is the refractive index of tissue (1.33). Transcranial optical pathlength was taken as the average of the 780-and 830-nm photon pathlengths. Cerebral hemoglobin concentration was determined from the absorption coefficients measured at 780 and 830 nm (14, 17) . Blood oxygen saturation and hemoglobin concentration were measured by CO-Oximetry (Instrumentation Laboratory, Lexington, MA), and blood partial pressure of carbon dioxide (Pco,) and oxygen (Po2) and pH were measured by a blood gas analyzer (Corning Instruments, Corning, NY).
Brain Model Studies
The brain model is a solid plastic structure containing a microvascular network perfused with human blood equilibrated with 0,, N,, and CO, in a closed circuit (14) . The model's vascular volume comprises 5% of its total volume to simulate normal cerebral blood volume. Blood oxygen saturation is regulated by adjusting the flow of 0, and N2 in the circuit and measured by CO-Oximetry from an aliquot of blood. Hemoglobin concentration is regulated by adjusting the quantity of blood and diluent in the circuit.
The effect of hemoglobin concentration and optical pathlength on the relationship between optical density difference and oxygen saturation was determined as follows. Fiberoptic bundles from the TRS instrument and the RunMan@ optical probe were placed against the side of the model next to each another. Human packed red blood cells diluted with 0.9% saline were added to the circuit to achieve the desired hemoglobin concentration.
Perfusate Pco, (40 torr), pH (7.40), and temperature (37°C) were held constant during all experiments.
As perfusate oxygen saturation was increased from 0% to 100% in approximately 20% increments, optical pathlength and optical density difference were recorded. Experiments were performed with perfusate hemoglobin concentrations of 15 g / dL, 10 g/ dL, and 7 g / dL. The effect of hemoglobin concentration on optical pathlength in the model was also determined with blood oxygen saturation held constant (100%). TRS optical fibers were positioned against the model as described above. As perfusate hemoglobin concentration was decreased from 15 g / dL to 6 g/ dL in 3-g / dL steps, optical pathlength was recorded. Hemoglobin concentration in the brain model (equivalent to H in Equation 1) was calculated as 5% of perfusate hemoglobin concentration, which corresponds to the channel volume per total volume of the model.
Piglet Studies
To evaluate the effect of hemoglobin concentration and optical pathlength on Sco, measured in vim, six piglets (aged 2-5 days, body weight 1.45-2.0 kg) were studied. Piglet studies were approved by our institutional animal care and use committee. After intramuscular ketamine (33 mglkg) and acepromazine (3.3 mglkg) were administered, the trachea was cannulated, and the lungs were mechanically ventilated. Catheters were inserted into the femoral artery to measure arterial saturation (SAOJ, into the external jugular vein to administer drugs, and into the superior sagittal sinus to measure cerebrovenous oxygen saturation (Svo,). Anesthesia was maintained with intravenous fentanyl (25 pg/ kg load, then 10 pg. kg-i . h-l), droperidol (250 pg * kg-i * h-l), and pancuronium (0.1 pg * kg-' * h-i). A RunMan@ (n = 5) or Invos 3100@ (n = 1) probe was set on the head (skin, scalp, and skull were intact) with the emitter and detector 1 cm lateral to and parallel with the sagittal suture. TRS fiberoptics were on the contralateral hemisphere mirroring RunMan@; TRS was not used with Invos 3100@. Weighted-average cerebral oxygen saturation (SMO,) was defined by SMO,=O.75(SVO,)+O.25(SAO,)
Inspired oxygen concentration and ventilatory rate were adjusted to force Svo, over a wide range: normoxia (Svo, 55%-70%), moderate hypoxia (Svo, 35%-45%), severe hypoxia (Svo, 15%-25%), and hypercapnia (Svo, SO%-95%). The order was selected at random. All piglets experienced each condition; normoxia was experienced twice. NIRS, TRS, and CO-Oximetry were recorded at each condition. The experiment was then repeated after isovolemic hemodilution with lactated Ringer's solution to decrease arterial hemoglobin concentration by approximately 3 g/ dL. At the end of the experiment, animals were killed with intravenous pentobarbital (100 mg/kg).
Statistical Analysis
Data are expressed as means -t SD or as ranges. NIRS Sco, and SMO, were compared by using regression tests, difference tests [Bland-Altman (18)], and split tests. Linear relationships were determined by least squares regression. Comparisons among animals or conditions were made by using analysis of variance. Bias and precision were defined as the mean + 2 SD of, respectively, the ordinate for SNIRSO~ -SMOG versus (SNIRSO~ + SMO~)/~. Homogeneity of the slopes, intercepts, and bias among piglets was assessed by analysis of covariance. The split test was the number of times NIRS Sco, "split" between arterial and cerebrovenous saturation. Significance was P < 0.05.
Results
In the brain model, linear relationships were observed between G and So, (Figure 1 ), consistent with Equation 1. Positive slope and negative intercept values reflect positive and negative values for k and k', respectively. When the hemoglobin concentration in the brain model was decreased, the slope decreased (P < 0.001) and the intercept increased (P < O.OOl), which is also consistent with Equation 1. The inflection point of the three lines occurred at So, = 55%, which indicates that as hemoglobin concentration decreases, NIRS underestimates Sco, above the inflection point and overestimates it below the inflection point. In the brain model, optical pathlength was inversely related to perfusate hemoglobin concentration. During variable oxygen saturation, optical pathlength measured at the perfusate hemoglobin concentration 7 g/dL (14.3 + 0.3 cm) was significantly greater than those at 10 g/dL (15.4 + 0.2 cm) and 15 g/dL (17.2 k 0.1 cm). During constant oxygen saturation, optical pathlength decreased linearly as perfusate hemoglobin concentration was decreased (Figure 2) .
In piglets, linear relationships were observed between RunMan@ oxygen saturation and SMO, (Table 1, Figure 3 ). Among animals, slopes ranged from 0.73 to 1.4, intercepts from 36 to -24, bias from -20% to 11%, and precision from 3% to 12%. There was significant interanimal variability (e.g., Piglet 1 versus Piglet 5) for slope (P < O.OOl), intercept (P < O.OOl), and bias (P < 0.05). In the split test, RunMan@ oxygen saturation did split arterial and cerebrovenous saturation in 19 of 25 comparisons (76%) and failed to split in 6 of 25 (24%). Among animals, transcranial optical pathlength ranged from 13.4 to 16.0 cm, and cerebral hemoglobin concentration ranged from 0.58 to 1.10 g/dL (Table 2) . There was significant interanimal variability in transcranial optical pathlength (P < O.OOl), arterial hemoglobin concentration (P < 0.05), and cerebral hemoglobin concentration (P < 0.01).
Several biologic factors were examined as sources for the interanimal variability of the RunMan@ Sco, versus SMO* line (Table 3) . Of the factors, only transcranial optical pathlength and cerebral hemoglobin concentration were significantly correlated with the slope and the intercept of the lines, in that animals with greater slope and lesser intercept had greater transcranial optical pathlength and cerebral hemoglobin concentration. Significant correlation was also observed between transcranial optical pathlength and cerebral hemoglobin concentration (r2 = 0.70, P = 0.03).
To determine whether the optical pathlength or cerebral hemoglobin measurements could be used to improve NIRS accuracy, the algorithm (Equation 1) was adjusted in each animal by stepwise linear regression with the optical pathlength and/or cerebral hemoglobin concentration measurements (Table 4) . When the data from all animals were combined and analyzed, the adjusted algorithms had slopes and intercepts closer to unity and zero, respectively, and improved precision compared with the unadjusted algorithm. When the animals' data were analyzed individually, the range among animals in slope, intercept, and precision was decreased for the adjusted algorithms. However, significant interanimal variability persisted, and there continued to be occasions on which RunMan@ Sco, did not split arterial and cerebrovenous saturation: 20% (5 of 20) for the pathlength adjusted algorithm, 16% (4 of 25) for the cerebral hemoglobinadjusted algorithm, and 20% (5 of 25) for the pathlengthcerebral hemoglobin-adjusted algorithm.
The effect of acute hemodilution was examined on SCO, measurements with the RunMan@ oximeter (Figure 4a ; Table 5 ) and the Invos 3100@ oximeter ( Figure  4b ). For both instruments, the slope of the NIRS oxygen saturation versus SMOG line was decreased (P < 0.01) and intercept was increased (P < 0.01) after hemodilution compared with before hemodilution. Hemodilution also increased transcranial optical pathlength (before versus after hemodilution: 13.9 t 1.1 vs 15.6 +-1.3 cm, P < 0.05) and decreased cerebral hemoglobin concentration (before versus after hemodilution: 0.98 k 0.24 vs 0.73 ? 0.25 g/dL, P < 0.05). The slope, intercept, and pathlength changes with hemodilution are consistent with those seen with decreasing perfusate hemoglobin concentration in the brain model experiments.
To determine whether optical pathlength or cerebral hemoglobin concentration could be used to improve NIRS accuracy with hemodilution, the NIRS algorithm (Equation 1) was adjusted by stepwise linear regression with the measured pathlength and cerebral hemoglobin values before and after hemodilution (Table  5 ). In the pathlength-adjusted algorithm, there continued to be significant changes in the slope of the NIRS oxygen saturation versus SMOG line before versus after hemodilution.
In the cerebral hemoglobin-and pathlength-cerebral hemoglobin-adjusted algorithms, slope and intercept remained unchanged. Hemodilution did not alter results of the difference or split tests for any of the algorithms. had limited clinical use because of concerns about its accuracy, in that studies have reported that although NIRS and SMOG correlate well, interpatient variability exists in slope, intercept, and bias between the measures (10, 11, 13) . In the present study, several lines of evidence indicate that intersubject variability originates, in part, from biologic variation in cerebral hemoglobin concentration and transcranial optical pathlength and its effect on the calculation of Sco, by the Lack of a gold standard for NIRS has complicated validation and identification of error sources. NIRS monitors a tissue field containing capillaries, arterioles, and venules, and its calculated oxygen saturation represents a mixed, microvascular oxygen saturation. No other method presently measures oxygen saturation in this region of the circulation. The brain model was developed as a means to better validate NIRS and identify error sources, because oxygen saturation and hemoglobin concentration in the model are known and can be varied independently. However, the brain model is limited by its simplicity and cannot replace biologic testing. Weighted-average oxygen saturation calculated from arterial and cerebral venous blood has been used to validate NIRS Sco, in viva (10, 11, 14) . However, it is an estimate that can introduce error because the ratio of arterial and venous blood may not be constant among subjects or conditions. The split test complements regression and differences tests because NIRS Sco, should always fall between arterial and venous saturation. In this study, we used the brain model, weighted-average estimate, and arterial-venous split to examine NIRS accuracy. These tests indicate that measurement errors do exist in certain subjects and during hemodilution and that variations in cerebral hemoglobin concentration and optical pathlength are sources of these errors.
NIRS include continuous wave instruments (cw-NIRS), time-resolved instruments (trNIRS), and phase-modulated instruments (pmNIRS). cwNIRS has been available commercially for several years and uses incoherent light technology. RunMan@ and Invos 31000 instruments are examples of cwNIRS. pmNIRS and trNIRS use coherent light technology and have the advantage of being able to measure optical pathlength as well as absorption (17). These instruments, however, remain under development, and their Sco, algorithms have not been tested. Previous work has found good correlation between cwNIRS and other measures of cerebral oxygen saturation (7, 10, 11, 13, 19) . observed linear relationships between Invos 31000 and SMOG in adult humans, although wide intersubject variability in slope (0.4-1.3), intercept (-23 to 30), and bias (-8 to 8) was noted between the measures. In our study, intersubject variability between RunMan@ and SMO, was similar to the findings of Pollard et al., even though different cw-NIRS instruments were used and different species were studied. In addition, our results for the hemodilution experiments were similar for RunMan@ and Invos 3100@ instruments. These findings suggest that Slopes and intercepts of the lines changed significantly before versus after hemodilution. Hb-blood hemoglobin concentration.
a, RunMane oximeter (Piglet 4, see Table 1 ). At Hb = 11.1 /dL, y = 19,?= .
0.92x + 13, Y' = 0.99. At Hb = 8.5 g/dL, y = 0.78x + 096
Slope and intercept comparison between lines, P < 0.025 and P < 0.05, respectively. b, Invos 31OOe oximeter. At Hb = 9.9 g/dL, y = 0.58x + 15, r2 = 0.88. At Hb = 7.1 g/dL, y = 0.36x + 38, r2 = 0.72. Slope and intercept comparison between lines were P < 0.005. intersubject variability originates in cwNIRS methodology, not the particular instrument, and reflects a limitation of cwNIRS technology.
Optical pathlength is an important factor in spectrophotometry through the Beer-Lambert law. In dilute, nonparticulate solutions, optical pathlength is the linear distance across the solution and is defined in benchtop spectrometers by the cuvette width (usually 1 cm). In particulate, highly scattering solutions such as tissue, optical pathlength is many times the linear distance across the solution. Computer simulations of optical paths in tissue describe photons traveling like pin balls deflecting off tissue particles (e.g., red blood cells, mitochondria) but roughly following an elliptical path between light emitter and detector (20) . Photon pathlength is influenced by emitter-detector separation (wider separation, longer path), tissue lightscattering properties (higher scatter, longer path), and tissue absorbance (higher absorption, shorter path) (14, 17, 21, 22) . Optical pathlength is also influenced by tissue boundaries, which, in the head, include interfaces among scalp, skull, cerebrospinal fluid, and brain (23).
Until recently, optical pathlength in NIRS has been unknown.
Advances in laser technology and electronics have now made it possible to measure optical pathlength by either trNIRS or frequency-resolved spectroscopy, which use the particle and wave properties of light, respectively (17). In the current study, optical pathlength was measured by trNIRS using the time-of-flight of photons, whereas in our previous studies, it was measured by frequency-resolved spectroscopy using a phase-shift of light waves (7, 22) . Both methods appear to yield similar optical pathlengths in piglets (7, 22) . Pathlength differences among subjects appears to arise from biologic variation in tissue light scattering, composition of tissue boundaries, and/or tissue absorption. The current study ties these biologic variations in optical pathlength to cwNIRS oxygen saturation measurement errors. The current study also identified cerebral hemoglobin concentration as a factor that influences cwNIRS saturation. Although optical pathlength and hemoglobin concentration are independent variables in the cwNIRS algorithm (Equation l), we did observe a significant relationship between them in both brain model and piglet experiments, consistent with the physics of light behavior in tissue (15, 17, 20) . This relationship minimized the error in calculating saturation during hemodilution because the increase in transcranial optical pathlength partially offset the decrease in cerebral hemoglobin concentration to help maintain constancy of the slope (LHk) and intercept (LHk) in the algorithm. This relationship also explains why the pathlength-hemoglobin-adjusted algorithm did not substantially improve that of either pathlength or hemoglobin alone.
Several studies have suggested the applicability of cwNIRS to cardiac operations and carotid endarterectomy to monitor the brain (l-4,13). Cerebral hemoglobin concentrations may decrease during carotid artery occlusion (ischemia) and during cardiopulmonary bypass (hemodilution) (24, 25) . Our data reveal that cw-NIRS overestimates Sco, when cerebral hemoglobin concentrations decrease, which suggests that during cardiac and cerebrovascular operations, these instruments may underestimate cerebral desaturation. The tissues overlying the brain can also influence the measurement of Sco,, and this is an important issue in applying NIRS to adults (10, 11, 19, 20, 23) . Because NIRS oxygen saturation originates from the illuminated volume of tissue beneath the probe, the measurement reflects the combined oxygen saturation of blood in the skin, scalp, skull, and brain. This illuminated tissue volume is determined by the absorbing and scattering properties of the tissue, the light emitter-detector separation on the NIRS probe, and the boundary conditions beneath the probe (17, 20, 23) . Depending on the boundary condition, light may be back-scattered or piped forward, hindering or facilitating, respectively, brain measurements from the surface of the head. However, increasing emitter-detector separations on the NIRS probe illuminates deeper tissue regions to facilitate brain measurements (23). The present study did not examine the influence of overlying tissues on NIRS Sco, measurements, as the in vitro brain model did not simulate the head with multiple tissue boundaries, and the overlying tissues in piglets are thin and do not affect NIRS measurements (W4).
Before NIRS can be used to manage patients, the accuracy of Sco, measurements should be improved, and the relationship between Sco, and brain injury should be defined better. By accounting for biologic variation in cerebral hemoglobin concentration and optical pathlength, cwNIRS accuracy can be increased. However, the approach of combining cwNIRS with a method to measure pathlength or cerebral hemoglobin concentration, such as trNIRS, was not entirely satisfactory. In addition, trNIRS is an expensive technology not easily used in the clinical environment. pm-NIRS or spatially-resolved instruments may be able to account for these factors and measure Sco, more accurately (17). Further work is required to develop and validate these instruments for clinical use. In the near-infrared spectrum between 750 and 850 nm, optical pathlength, light scattering, and background tissue absorption remain relatively constant, and it is possible to select wavelength pairs in which the extinctions of oxy-and deoxyhemoglobin differ (14, (26) (27) (28) .
